UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:HSD17B12-WT1 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: HSD17B12-WT1 | FusionPDB ID: 37666 | FusionGDB2.0 ID: 37666 | Hgene | Tgene | Gene symbol | HSD17B12 | WT1 | Gene ID | 51144 | 7490 |
Gene name | hydroxysteroid 17-beta dehydrogenase 12 | WT1 transcription factor | |
Synonyms | KAR|SDR12C1 | AWT1|GUD|NPHS4|WAGR|WIT-2|WT33 | |
Cytomap | 11p11.2 | 11p13 | |
Type of gene | protein-coding | protein-coding | |
Description | very-long-chain 3-oxoacyl-CoA reductase17-beta-HSD 1217-beta-hydroxysteroid dehydrogenase 1217beta-HSD type 123-ketoacyl-CoA reductaseestradiol 17-beta-dehydrogenase 12short chain dehydrogenase/reductase family 12C member 1steroid dehydrogenase hom | Wilms tumor proteinWilms tumor 1 | |
Modification date | 20200313 | 20200320 | |
UniProtAcc | Q53GQ0 | P19544 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000278353, ENST00000395700, ENST00000529261, | ENST00000332351, ENST00000379079, ENST00000448076, ENST00000530998, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 13 X 13 X 7=1183 | 3 X 6 X 5=90 |
# samples | 14 | 4 | |
** MAII score | log2(14/1183*10)=-3.07895134139482 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/90*10)=-1.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: HSD17B12 [Title/Abstract] AND WT1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | HSD17B12(43702537)-WT1(32450165), # samples:4 | ||
Anticipated loss of major functional domain due to fusion event. | HSD17B12-WT1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. HSD17B12-WT1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. HSD17B12-WT1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. HSD17B12-WT1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | WT1 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 7585606 |
Tgene | WT1 | GO:0007530 | sex determination | 9815658 |
Tgene | WT1 | GO:0008285 | negative regulation of cell proliferation | 9553041|9765217 |
Tgene | WT1 | GO:0030308 | negative regulation of cell growth | 9553041|9765217 |
Tgene | WT1 | GO:0045892 | negative regulation of transcription, DNA-templated | 1332065|7585606|7720589|8119964|12802290|14701728|19050011 |
Tgene | WT1 | GO:0045893 | positive regulation of transcription, DNA-templated | 8132626|9178767|9553041|9765217|12802290|14701728|16467207|21390327 |
Tgene | WT1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 23042785 |
Tgene | WT1 | GO:0071371 | cellular response to gonadotropin stimulus | 15961562 |
Fusion gene breakpoints across HSD17B12 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across WT1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | KICH | TCGA-KL-8335-01A | HSD17B12 | chr11 | 43702537 | - | WT1 | chr11 | 32450165 | - |
ChimerDB4 | KICH | TCGA-KL-8335-01A | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - |
ChimerDB4 | KICH | TCGA-KL-8335 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000278353 | HSD17B12 | chr11 | 43702537 | + | ENST00000379079 | WT1 | chr11 | 32450165 | - | 2461 | 279 | 119 | 1177 | 352 |
ENST00000278353 | HSD17B12 | chr11 | 43702537 | + | ENST00000332351 | WT1 | chr11 | 32450165 | - | 2470 | 279 | 119 | 1186 | 355 |
ENST00000278353 | HSD17B12 | chr11 | 43702537 | + | ENST00000530998 | WT1 | chr11 | 32450165 | - | 2416 | 279 | 119 | 1135 | 338 |
ENST00000278353 | HSD17B12 | chr11 | 43702537 | + | ENST00000448076 | WT1 | chr11 | 32450165 | - | 1557 | 279 | 119 | 1177 | 352 |
ENST00000395700 | HSD17B12 | chr11 | 43702537 | + | ENST00000379079 | WT1 | chr11 | 32450165 | - | 2389 | 207 | 47 | 1105 | 352 |
ENST00000395700 | HSD17B12 | chr11 | 43702537 | + | ENST00000332351 | WT1 | chr11 | 32450165 | - | 2398 | 207 | 47 | 1114 | 355 |
ENST00000395700 | HSD17B12 | chr11 | 43702537 | + | ENST00000530998 | WT1 | chr11 | 32450165 | - | 2344 | 207 | 47 | 1063 | 338 |
ENST00000395700 | HSD17B12 | chr11 | 43702537 | + | ENST00000448076 | WT1 | chr11 | 32450165 | - | 1485 | 207 | 47 | 1105 | 352 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000278353 | ENST00000379079 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.015225739 | 0.98477423 |
ENST00000278353 | ENST00000332351 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.015108737 | 0.98489124 |
ENST00000278353 | ENST00000530998 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.009088906 | 0.99091107 |
ENST00000278353 | ENST00000448076 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.11383599 | 0.88616407 |
ENST00000395700 | ENST00000379079 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.015235038 | 0.98476493 |
ENST00000395700 | ENST00000332351 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.015001932 | 0.98499805 |
ENST00000395700 | ENST00000530998 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.008630293 | 0.9913697 |
ENST00000395700 | ENST00000448076 | HSD17B12 | chr11 | 43702537 | + | WT1 | chr11 | 32450165 | - | 0.103710964 | 0.896289 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >37666_37666_1_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000278353_WT1_chr11_32450165_ENST00000332351_length(amino acids)=355AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_2_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000278353_WT1_chr11_32450165_ENST00000379079_length(amino acids)=352AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_3_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000278353_WT1_chr11_32450165_ENST00000448076_length(amino acids)=352AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_4_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000278353_WT1_chr11_32450165_ENST00000530998_length(amino acids)=338AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGHSTGYESDNHTTPILCGAQYRIHTH GVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRFSRSDQLKRHQRRHTGVK -------------------------------------------------------------- >37666_37666_5_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000395700_WT1_chr11_32450165_ENST00000332351_length(amino acids)=355AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_6_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000395700_WT1_chr11_32450165_ENST00000379079_length(amino acids)=352AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_7_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000395700_WT1_chr11_32450165_ENST00000448076_length(amino acids)=352AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF -------------------------------------------------------------- >37666_37666_8_HSD17B12-WT1_HSD17B12_chr11_43702537_ENST00000395700_WT1_chr11_32450165_ENST00000530998_length(amino acids)=338AA_BP=52 MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGHSTGYESDNHTTPILCGAQYRIHTH GVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRFSRSDQLKRHQRRHTGVK -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:43702537/chr11:32450165) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
HSD17B12 | WT1 |
FUNCTION: Catalyzes the second of the four reactions of the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of two carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. This enzyme has a 3-ketoacyl-CoA reductase activity, reducing 3-ketoacyl-CoA to 3-hydroxyacyl-CoA, within each cycle of fatty acid elongation. Thereby, it may participate in the production of VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May also catalyze the transformation of estrone (E1) into estradiol (E2) and play a role in estrogen formation. {ECO:0000269|PubMed:12482854, ECO:0000269|PubMed:16166196}. | FUNCTION: Transcription factor that plays an important role in cellular development and cell survival (PubMed:7862533). Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3' (PubMed:7862533, PubMed:17716689, PubMed:25258363). Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors (PubMed:15520190). Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing (PubMed:16934801). Isoform 1 has lower affinity for DNA, and can bind RNA (PubMed:19123921). {ECO:0000269|PubMed:15520190, ECO:0000269|PubMed:16934801, ECO:0000269|PubMed:17716689, ECO:0000269|PubMed:19123921, ECO:0000269|PubMed:19416806, ECO:0000269|PubMed:25258363, ECO:0000269|PubMed:7862533}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | HSD17B12 | chr11:43702537 | chr11:32450165 | ENST00000278353 | + | 1 | 11 | 4_24 | 53.333333333333336 | 313.0 | Transmembrane | Helical |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 27_83 | 3.3333333333333335 | 303.0 | Compositional bias | Note=Pro-rich | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 27_83 | 3.3333333333333335 | 289.0 | Compositional bias | Note=Pro-rich | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 236_244 | 3.3333333333333335 | 303.0 | Motif | 9aaTAD | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 236_244 | 3.3333333333333335 | 289.0 | Motif | 9aaTAD | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 323_347 | 3.3333333333333335 | 303.0 | Zinc finger | C2H2-type 1 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 353_377 | 3.3333333333333335 | 303.0 | Zinc finger | C2H2-type 2 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 383_405 | 3.3333333333333335 | 303.0 | Zinc finger | C2H2-type 3 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000379079 | 0 | 10 | 414_438 | 3.3333333333333335 | 303.0 | Zinc finger | C2H2-type 4 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 323_347 | 3.3333333333333335 | 289.0 | Zinc finger | C2H2-type 1 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 353_377 | 3.3333333333333335 | 289.0 | Zinc finger | C2H2-type 2 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 383_405 | 3.3333333333333335 | 289.0 | Zinc finger | C2H2-type 3 | |
Tgene | WT1 | chr11:43702537 | chr11:32450165 | ENST00000530998 | 0 | 9 | 414_438 | 3.3333333333333335 | 289.0 | Zinc finger | C2H2-type 4 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | HSD17B12 | chr11:43702537 | chr11:32450165 | ENST00000278353 | + | 1 | 11 | 308_312 | 53.333333333333336 | 313.0 | Motif | Note=Di-lysine motif |
Hgene | HSD17B12 | chr11:43702537 | chr11:32450165 | ENST00000278353 | + | 1 | 11 | 50_79 | 53.333333333333336 | 313.0 | Nucleotide binding | NADP |
Hgene | HSD17B12 | chr11:43702537 | chr11:32450165 | ENST00000278353 | + | 1 | 11 | 182_202 | 53.333333333333336 | 313.0 | Transmembrane | Helical |
Hgene | HSD17B12 | chr11:43702537 | chr11:32450165 | ENST00000278353 | + | 1 | 11 | 271_291 | 53.333333333333336 | 313.0 | Transmembrane | Helical |
Top |
Fusion Protein Structures |
PDB and CIF files of the predicted fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file >>>694_HSD17B12_43702537_WT1_32450165_ranked_0.pdb | HSD17B12 | 43702537 | 43702537 | ENST00000448076 | WT1 | chr11 | 32450165 | - | MESALPAAGFLYWVGAGTVAYLALRISYSLFTALRVWGVGNEAGVGPGLGEWAGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQ QGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESD NHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRF | 355 |
Top |
pLDDT score distribution |
pLDDT score distribution of the predicted wild-type structures of two partner proteins from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
HSD17B12_pLDDT.png |
WT1_pLDDT.png |
pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
Top |
Ramachandran Plot of Fusion Protein Structure |
Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
HSD17B12 | |
WT1 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to HSD17B12-WT1 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to HSD17B12-WT1 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | WT1 | C0950121 | Denys-Drash Syndrome | 20 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | WT1 | C0027708 | Nephroblastoma | 8 | CGI;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | WT1 | C3151568 | NEPHROTIC SYNDROME, TYPE 4 | 6 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | WT1 | C0950122 | Frasier Syndrome | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | WT1 | C1837026 | MEACHAM SYNDROME (disorder) | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | WT1 | C0023467 | Leukemia, Myelocytic, Acute | 2 | CGI;CTD_human |
Tgene | WT1 | C0026998 | Acute Myeloid Leukemia, M1 | 2 | CTD_human |
Tgene | WT1 | C0345967 | Malignant mesothelioma | 2 | CTD_human;GENOMICS_ENGLAND |
Tgene | WT1 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 2 | CTD_human |
Tgene | WT1 | C2930471 | Bilateral Wilms Tumor | 2 | CTD_human |
Tgene | WT1 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Tgene | WT1 | C0007102 | Malignant tumor of colon | 1 | CTD_human |
Tgene | WT1 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Tgene | WT1 | C0017636 | Glioblastoma | 1 | CTD_human |
Tgene | WT1 | C0017658 | Glomerulonephritis | 1 | CTD_human |
Tgene | WT1 | C0018054 | Gonadal Dysgenesis, 46,XY | 1 | ORPHANET |
Tgene | WT1 | C0019284 | Diaphragmatic Hernia | 1 | CTD_human |
Tgene | WT1 | C0023418 | leukemia | 1 | CTD_human |
Tgene | WT1 | C0023473 | Myeloid Leukemia, Chronic | 1 | CTD_human |
Tgene | WT1 | C0023487 | Acute Promyelocytic Leukemia | 1 | CTD_human |
Tgene | WT1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
Tgene | WT1 | C0027809 | Neurilemmoma | 1 | CTD_human |
Tgene | WT1 | C0029463 | Osteosarcoma | 1 | CTD_human |
Tgene | WT1 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
Tgene | WT1 | C0031149 | Peritoneal Neoplasms | 1 | CTD_human |
Tgene | WT1 | C0085215 | Ovarian Failure, Premature | 1 | CTD_human |
Tgene | WT1 | C0086367 | Gonadotropin-Resistant Ovary Syndrome | 1 | CTD_human |
Tgene | WT1 | C0206115 | WAGR Syndrome | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | WT1 | C0235833 | Congenital diaphragmatic hernia | 1 | CTD_human |
Tgene | WT1 | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
Tgene | WT1 | C0265699 | Congenital hernia of foramen of Morgagni | 1 | CTD_human |
Tgene | WT1 | C0265700 | Congenital hernia of foramen of Bochdalek | 1 | CTD_human |
Tgene | WT1 | C0334588 | Giant Cell Glioblastoma | 1 | CTD_human |
Tgene | WT1 | C0346647 | Malignant neoplasm of pancreas | 1 | CTD_human |
Tgene | WT1 | C0346990 | Carcinomatosis of peritoneal cavity | 1 | CTD_human |
Tgene | WT1 | C0678222 | Breast Carcinoma | 1 | CTD_human |
Tgene | WT1 | C0751374 | Schwannomatosis, Plexiform | 1 | CTD_human |
Tgene | WT1 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Tgene | WT1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | WT1 | C1621958 | Glioblastoma Multiforme | 1 | CTD_human |
Tgene | WT1 | C1704377 | Bright Disease | 1 | CTD_human |
Tgene | WT1 | C1840452 | Hyaloideoretinal degeneration of Wagner | 1 | GENOMICS_ENGLAND |
Tgene | WT1 | C1868672 | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1 | ORPHANET |
Tgene | WT1 | C2931803 | Deletion 11p13 | 1 | ORPHANET |
Tgene | WT1 | C2936694 | Swyer Syndrome | 1 | ORPHANET |
Tgene | WT1 | C3494522 | Hypergonadotropic Ovarian Failure, X-Linked | 1 | CTD_human |
Tgene | WT1 | C4510744 | 46,XY partial gonadal dysgenesis | 1 | ORPHANET |
Tgene | WT1 | C4552079 | Premature Ovarian Failure 1 | 1 | CTD_human |
Tgene | WT1 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |